Pulmonary Venoplasty in Lung Cancer Surgery: A Report of Nine Cases

Jiandong Mei,Lunxu Liu
DOI: https://doi.org/10.1200/jco.2014.32.15_suppl.e18526
IF: 45.3
2014-01-01
Journal of Clinical Oncology
Abstract:e18526 Background: Pulmonary resection combined with venoplasty is rarely performed with the aim of preserving more pulmonary function for selected patients. The objective of this study is to determine the feasibility and long term results of pulmonary venoplasty in surgical treatment of non-small cell lung cancer (NSCLC). Methods: Between 2006 and 2012, nine patients with proven NSCLC underwent anatomic pulmonary resection combined with venoplasty. The indications of vascular plasty included six cases of tumor in the middle lobar orifice involving the superior pulmonary vein, one case of metastatic lymph node involving the superior pulmonary vein, one case of venous injury due to dense adhesion and one case of injury due to venous anatomic variation. The operations were carried out with venous partial resection in four patients and sleeve resection in five patients. The vessel was reconstructed with continuous suture using 5-0 Prolene stitches. Results: The operations were finished within 110 to 410 min (median, 270 min). Blood loss ranged from 200 to 600 ml (median, 290ml) and no blood transfusion was required. Three patients had stage IIIa-N1 NSCLC, two patients had stage IIIa-N2 disease, and the other four patients were staged as Ia, Ib, IIa and IV NSCLC, respectively. The patients recovered uneventfully and were discharged home in 5 to 10 days (median, 7 days) after surgery. Postoperative follow up varied from 7 to 83 months and ideal patency of the pulmonary vein was confirmed in all patients. One patient was lost to follow up. Two patients died of metastasis 7 and 8 months after surgery respectively. Three patients had metastatic diseases at 14, 32 and 35 months after surgery, and they are still alive during 56-, 50- and 48-month follow-up. The other three patients have no signs of recurrence or metastasis during 16-, 39- and 83-month follow-up, respectively. Conclusions: Pulmonary resection combined with venoplasty is mainly performed in cases of middle lobar tumor involving the superior pulmonary vein. The operation is safe and feasible.It may be beneficial to some patients in preserving more pulmonary parenchyma and long term survival may be achieved in selected patients.
What problem does this paper attempt to address?